Immunovant (IMVT) Interest Coverage Ratio (2019)

Immunovant (IMVT) has 8 years of Interest Coverage Ratio data on file, last reported at 0.52 in Q1 2026.

• Quarterly Interest Coverage Ratio changed 0.16% year-over-year to 0.52 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.15 (down 92.66% YoY) and the FY2026 annual result came in at 0.62, up 30.15% from the prior year.
• Interest Coverage Ratio rose to 0.52 in Q1 2026, from 0.07 in the prior quarter.
• In the past five years, Interest Coverage Ratio ranged from a high of 0.88 in Q4 2023 to a low of 3077.54 in Q2 2022.
• A 5-year average of 195.85 and a median of 0.38 in 2024 frame the typical range for Interest Coverage Ratio.
• Annual changes were most pronounced in 2022 — Interest Coverage Ratio plunged 111913.04% — and 2023, when it soared 104.36%.
• Tracing IMVT's Interest Coverage Ratio over 5 years: stood at 0.45 in 2022, then surged by 94.9% to 0.88 in 2023, then tumbled by 56.85% to 0.38 in 2024, then sank by 81.75% to 0.07 in 2025, then jumped by 646.21% to 0.52 in 2026.
• The last three Interest Coverage Ratio figures came in at 0.52 (Q1 2026), 0.07 (Q4 2025), and 1.62 (Q3 2025), per Business Quant data.